10-Q Filing

NEUROCRINE BIOSCIENCES INC CIK: 914475 Q3 2017

Filing Information

Form Type	10-Q
Accession Number	`0001193125-17-329460`
Period End Date	20170930
Filing Date	20171101
Fiscal Year	2017
Fiscal Period	Q3
XBRL Instance	nbix-20170930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 76 Cash Flow Statement 63

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$99.76M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$74.19M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$267.82M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$83.27M	USD	Point-in-time
Short-term investments, available-for-sale	`AvailableForSaleSecuritiesCurrent`	$243.20M	USD	Point-in-time
Short-term investments, available-for-sale	`AvailableForSaleSecuritiesCurrent`	$224.08M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$29.82M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Inventory	`InventoryNet`	$242.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.09M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$7.41M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	88.46M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	86.88M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	86.88M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$548.49M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	88.46M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$310.44M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.14M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.27M	USD	Point-in-time
Long-term investments, available-for-sale	`AvailableForSaleSecuritiesNoncurrent`	$210.26M	USD	Point-in-time
Long-term investments, available-for-sale	`AvailableForSaleSecuritiesNoncurrent`	$43.49M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.61M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.88M	USD	Point-in-time
Total assets	`Assets`	$772.50M	USD	Point-in-time
Total assets	`Assets`	$365.09M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$26.18M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$37.29M	USD	Point-in-time
Current portion of cease-use liability	`CeaseUseLiabilityCurrent`	$236.00K	USD	Point-in-time
Current portion of cease-use liability	`CeaseUseLiabilityCurrent`	$121.00K	USD	Point-in-time
Current portion of deferred rent	`DeferredRentCreditCurrent`	$470.00K	USD	Point-in-time
Current portion of deferred rent	`DeferredRentCreditCurrent`	-	USD	Point-in-time
Current portion of deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateCurrent`	$3.53M	USD	Point-in-time
Current portion of deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateCurrent`	$731.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$30.41M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$38.14M	USD	Point-in-time
Deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateNoncurrent`	$8.23M	USD	Point-in-time
Deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateNoncurrent`	$7.37M	USD	Point-in-time
Deferred revenue	`DeferredRevenueNoncurrent`	$10.23M	USD	Point-in-time
Deferred revenue	`DeferredRevenueNoncurrent`	$10.23M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$1.46M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$3.16M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	$365.11M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	-	USD	Point-in-time
Cease-use liability	`CeaseUseLiabilityNoncurrent`	$617.00K	USD	Point-in-time
Cease-use liability	`CeaseUseLiabilityNoncurrent`	-	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$113.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$113.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$50.21M	USD	Point-in-time
Total liabilities	`Liabilities`	$424.98M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 220,000,000 shares authorized; issued and outstanding shares were 88,462,002 as of September 30, 2017 and 86,883,300 as of December 31, 2016	`CommonStockValue`	$88.00K	USD	Point-in-time
Common stock, $0.001 par value; 220,000,000 shares authorized; issued and outstanding shares were 88,462,002 as of September 30, 2017 and 86,883,300 as of December 31, 2016	`CommonStockValue`	$87.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.37B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.55B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-318.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-534.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.21B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.06B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$347.51M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$314.88M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$772.50M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$365.09M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Product sales, net	`SalesRevenueGoodsNet`	$52.11M	USD	3 Qtrs
Product sales, net	`SalesRevenueGoodsNet`	-	USD	1 Quarter
Product sales, net	`SalesRevenueGoodsNet`	-	USD	3 Qtrs
Product sales, net	`SalesRevenueGoodsNet`	$45.77M	USD	1 Quarter
License fees and milestones	`LicensesRevenue`	-	USD	1 Quarter
License fees and milestones	`LicensesRevenue`	$15.00M	USD	1 Quarter
License fees and milestones	`LicensesRevenue`	$15.00M	USD	3 Qtrs
License fees and milestones	`LicensesRevenue`	$15.00M	USD	3 Qtrs
Total revenues	`Revenues`	-	USD	1 Quarter
Total revenues	`Revenues`	$15.00M	USD	3 Qtrs
Total revenues	`Revenues`	$67.11M	USD	3 Qtrs
Total revenues	`Revenues`	$60.77M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	-	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	-	USD	3 Qtrs
Cost of product sales	`CostOfGoodsSold`	$494.00K	USD	3 Qtrs
Cost of product sales	`CostOfGoodsSold`	$433.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$96.21M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$20.94M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$22.46M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$71.71M	USD	3 Qtrs
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$44.41M	USD	3 Qtrs
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$113.60M	USD	3 Qtrs
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$43.87M	USD	1 Quarter
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$17.49M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$116.12M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$38.44M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$210.30M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$66.77M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-101.12M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-38.44M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-6.00M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-143.19M	USD	3 Qtrs
Gain/(loss) on sale/disposal of assets	`NonoperatingGainLossOnDispositionOfAssets`	$5.00K	USD	1 Quarter
Gain/(loss) on sale/disposal of assets	`NonoperatingGainLossOnDispositionOfAssets`	$-9.00K	USD	1 Quarter
Gain/(loss) on sale/disposal of assets	`NonoperatingGainLossOnDispositionOfAssets`	$8.00K	USD	3 Qtrs
Gain/(loss) on sale/disposal of assets	`NonoperatingGainLossOnDispositionOfAssets`	$7.00K	USD	3 Qtrs
Deferred gain on real estate	`DeferredGainOnSaleOfRealEstate`	$2.56M	USD	3 Qtrs
Deferred gain on real estate	`DeferredGainOnSaleOfRealEstate`	$853.00K	USD	1 Quarter
Deferred gain on real estate	`DeferredGainOnSaleOfRealEstate`	$183.00K	USD	1 Quarter
Deferred gain on real estate	`DeferredGainOnSaleOfRealEstate`	$1.94M	USD	3 Qtrs
Interest expense	`InterestExpense`	$7.34M	USD	1 Quarter
Interest expense	`InterestExpense`	-	USD	3 Qtrs
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$12.10M	USD	3 Qtrs
Investment income, net	`InvestmentIncomeNet`	$2.12M	USD	3 Qtrs
Investment income, net	`InvestmentIncomeNet`	$2.02M	USD	1 Quarter
Investment income, net	`InvestmentIncomeNet`	$3.92M	USD	3 Qtrs
Investment income, net	`InvestmentIncomeNet`	$705.00K	USD	1 Quarter
Total other (expense) income	`NonoperatingIncomeExpense`	$1.55M	USD	1 Quarter
Total other (expense) income	`NonoperatingIncomeExpense`	$-5.13M	USD	1 Quarter
Total other (expense) income	`NonoperatingIncomeExpense`	$4.69M	USD	3 Qtrs
Total other (expense) income	`NonoperatingIncomeExpense`	$-6.24M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-11.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-96.43M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-36.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-149.44M	USD	3 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.70	USD	3 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.11	USD	3 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.43	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.13	USD	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	86.66M	shares	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	88.33M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	87.89M	shares	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	86.78M	shares	1 Quarter
Net loss	`NetIncomeLoss`	$-11.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-96.43M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-36.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-149.44M	USD	3 Qtrs
Net unrealized gains/(losses) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$790.00K	USD	3 Qtrs
Net unrealized gains/(losses) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-216.00K	USD	3 Qtrs
Net unrealized gains/(losses) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$179.00K	USD	1 Quarter
Net unrealized gains/(losses) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-148.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-10.95M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-149.65M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-37.03M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-95.64M	USD	3 Qtrs

Cash Flow Statement 63 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-11.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-96.43M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-36.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-149.44M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.69M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.01M	USD	3 Qtrs
Gain on sale of assets	`GainsLossesOnSalesOfAssets`	$2.57M	USD	3 Qtrs
Gain on sale of assets	`GainsLossesOnSalesOfAssets`	$1.95M	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredLiabilities`	$-208.00K	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredLiabilities`	$1.23M	USD	3 Qtrs
Cease-use expense	`IncreaseDecreaseInCeaseUseExpense`	$-544.00K	USD	3 Qtrs
Cease-use expense	`IncreaseDecreaseInCeaseUseExpense`	$-584.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$526.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$6.75M	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	3 Qtrs
Amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.20M	USD	3 Qtrs
Amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-3.15M	USD	3 Qtrs
Non-cash share-based compensation expense	`ShareBasedCompensation`	$29.07M	USD	3 Qtrs
Non-cash share-based compensation expense	`ShareBasedCompensation`	$20.51M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$29.82M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$242.00K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	-	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-34.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$4.32M	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$11.11M	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$878.00K	USD	3 Qtrs
Cease-use liability	`IncreaseDecreaseInCeaseUseLiability`	$-239.00K	USD	3 Qtrs
Cease-use liability	`IncreaseDecreaseInCeaseUseLiability`	$-188.00K	USD	3 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-108.00K	USD	3 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-74.56M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-134.91M	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$444.54M	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$217.14M	USD	3 Qtrs
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$257.24M	USD	3 Qtrs
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$318.78M	USD	3 Qtrs
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$7.00K	USD	3 Qtrs
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$13.00K	USD	3 Qtrs
Deposits and restricted cash	`IncreaseDecreaseInRestrictedCash`	$92.00K	USD	3 Qtrs
Deposits and restricted cash	`IncreaseDecreaseInRestrictedCash`	$-270.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.76M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.56M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-191.59M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$97.80M	USD	3 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$8.27M	USD	3 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$2.33M	USD	3 Qtrs
Proceeds from issuance of senior convertible notes, net	`ProceedsFromConvertibleDebt`	$502.78M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.33M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$511.05M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$25.57M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$184.55M	USD	3 Qtrs
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$99.76M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$74.19M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$267.82M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$83.27M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$99.76M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$74.19M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$267.82M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$83.27M	USD	Point-in-time
Cash paid for interest during the period	`InterestPaid`	-	USD	3 Qtrs
Cash paid for interest during the period	`InterestPaid`	-	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.